Hanmi Spurs New Immunotherapy Development Through Open Innovation

By • on September 18, 2019

The Korea Biomedical Review reported that Hanmi Pharmaceutica is launching new development projects in the field of dual- and multi-antibody-based immunotherapy drugs through open innovation with external technologies. The company’s open innovation projects include a licensing-in deal for an antibody from Phanes Therapeutics’, a U.S. biopharmaceutical firm, and expanding new drug development program for Pentambody, a platform technology developed by Beijing Hanmi Pharmaceutical, the company’s Chinese offshoot.

Click here to read the full article.

Image via Flickr.

Related Posts

Related Entries

Recent Entries

Purchase viagra online and purchase it from the good to cope with dependable and trustworthy pharmacy. Don't believe of the recommendation by a mantra but instead as suggestion that is useful since that might be really a correct move to make to think about. It's not just about general ease of doing all of your buying resting before your Computer, or around no prerequisite to depart your home or stand-in point, but additionally concerning the choices you might have barely considered overall. Visit the drugstore you might have handled earlier in the event that you know the thing you need precisely. Examine the options what, why and just how if, nevertheless, you will find neither particular needs or a drugstore to go to.